<DOC>
	<DOCNO>NCT00421655</DOCNO>
	<brief_summary>The trial perform evaluate efficacy safety specific immunotherapy Grazax treatment grass pollen induce allergy .</brief_summary>
	<brief_title>A Trial Grazax Subjects With Hayfever</brief_title>
	<detailed_description />
	<criteria>History grass pollen allergy Positive skin prick test grass Positive specific IgE grass Exclusion Criteria FEV1 &lt; 70 % predict value</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>